KRO vs CE vs OLN Stock Comparison

Kronos Worldwide, Celanese and Olin Prices as of Oct 26, 2026 Peers: Industry group
KRO Kronos Worldwide Inc
$7.60 -7.9% 1M +53.5% 1Y
Market cap
$888.57M
P/E
–
Revenue (TTM)
$1.94B
Div. yield
0.03%
Commodity Chemicals Basic Materials
4 wins
CE Celanese Corp
$48.10 +2.2% 1M +14.0% 1Y
Market cap
$5.36B
P/E
–
Revenue (TTM)
$9.71B
Div. yield
0.00%
Commodity Chemicals Basic Materials
3 wins
OLN OLIN Corp
$15.94 -2.9% 1M -33.7% 1Y
Market cap
$1.83B
P/E
–
Revenue (TTM)
$6.70B
Div. yield
–
Commodity Chemicals Basic Materials
4 wins

Head to Head

11 decided of 12

Kronos Worldwide leads on 4 of the 12 questions below (Kronos Worldwide 4, Olin 4, Celanese 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionKROCEOLNLeader
Larger companyMarket capitalisation $888.57M $5.36B $1.83B CE
Cheaper on earningsLower P/E, profitable companies only -8.1x -4.6x -9.3x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 20.0x 7.6x — CE
Faster revenue growthRevenue growth, trailing twelve months +2.7% -2.2% +0.6% KRO
More profitableNet margin, trailing twelve months -5.6% -12.0% -2.9% OLN
Better return on capitalReturn on invested capital -2.4% -4.1% -1.6% OLN
Less leveragedLower net debt / EBITDA 17.7x 63.7x 7.3x OLN
Higher dividend yieldTrailing dividend yield 0.03% 0.00% 0.00% KRO
Better 1-year returnPrice return, last 12 months +53.5% +14.0% -33.7% KRO
Better 5-year returnAnnualised price return, 5 years -10.1%/yr -21.7%/yr -22.0%/yr KRO
Less volatileAnnualised volatility, 1 year 59.2% 51.7% 53.3% CE
Higher overall scoreMean of the five percentile scores vs peers 42/100 29/100 44/100 OLN

Percentile Scorecard

KROCEOLN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisKROCEOLN
Valuation 70 #29 of 94 58 #40 of 94 76 #23 of 94
Growth 37 #58 of 92 23 #71 of 92 3 #89 of 92
Profitability 28 #64 of 89 32 #61 of 89 38 #56 of 89
Financial Health 38 #61 of 97 13 #85 of 97 16 #82 of 97
Shareholder Returns 36 #45 of 70 22 #55 of 70 88 #9 of 70
Overall 42 29 44
  • KRO ranked among 99 companies in Chemicals
  • CE ranked among 99 companies in Chemicals
  • OLN ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodKROCEOLNSPY
1 month -7.9%+2.2%-2.9% -0.8%
3 months +24.0%+8.4%-27.1% +3.5%
6 months +4.4%-26.1%-40.6% +7.0%
Year to date +71.9%+13.8%-23.5% +12.2%
1 year +53.5%+14.0%-33.7% +13.0%
3 years +14.3%-57.6%-62.2% +86.3%
3 years, per year +4.6%-24.9%-27.7% +23.1%
5 years -41.3%-70.6%-71.1% +68.6%
5 years, per year -10.1%-21.7%-22.0% +11.0%
10 years -3.3%-32.4%-27.4% +258.0%
10 years, per year -0.3%-3.8%-3.2% +13.6%

Risk

MeasureKROCEOLNSPY
Volatility, 1Y 59.2%51.7%53.3% 12.7%
Downside volatility, 1Y 47.7%47.1%57.5% 12.7%
Beta vs S&P 500, 1Y 1.260.400.42 1.00
Return / volatility, 1Y 0.900.27-0.63 1.02
Max drawdown, 5Y -77.9%-79.6%-78.0% -25.4%
From 52-week high -14.7%-30.5%-47.1% -1.8%
52-week high $8.91$69.24$30.14 $779.14
52-week low $4.33$35.53$14.72 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleKROCEOLN
P/E now vs peer median -8.0xmedian 21.6x -4.5xmedian 21.6x -9.2xmedian 21.6x
P/S now vs peer median 0.5xmedian 1.4x 0.5xmedian 1.4x 0.3xmedian 1.4x
EV/EBITDA now vs peer median 46.3xmedian 12.4x 95.3xmedian 12.4x 11.9xmedian 12.4x
P/FCF now vs peer median 13.2xmedian 15.8x 7.5xmedian 15.8x 18.1xmedian 15.8x
P/B now vs peer median 1.2xmedian 1.6x 1.2xmedian 1.6x 1.1xmedian 1.6x
PEG now vs peer median 0.19median 1.66 0.11median 1.66 0.29median 1.66

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsKROCEOLN
Revenue $1.94B $9.71B $6.70B
Gross profit $229.50M $2.03B $460.70M
Operating income -$32.10M -$692.00M -$105.50M
Net income -$109.40M -$1.16B -$195.80M
Free cash flow $66.50M $708.00M $100.60M
R&D – $120.00M –
EPS (diluted) $-0.95 $-10.60 $-1.73
Cash & equivalents $26.60M $1.36B $177.40M
Total debt $569.60M $12.01B $3.03B
Shares (diluted) 115.10M 110.25M 113.90M
Enterprise value $775.37M -$461.34M $1.16B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricKROCEOLN
P/E -8.0x -4.5x -9.2x
P/FCF 13.2x 7.5x 18.1x
P/Operating cash flow 10.1x 5.4x 5.9x
P/S 0.5x 0.5x 0.3x
P/B 1.2x 1.2x 1.1x
P/Tangible book 1.2x 3.5x 1.2x
EV/EBITDA 46.3x 95.3x 11.9x
EV/EBIT -44.2x -23.0x -44.3x
EV/Revenue 0.7x 1.6x 0.7x
EV/FCF 21.3x 22.5x 46.4x
EV/Operating cash flow 16.4x 16.2x 15.2x
PEG (3Y EPS CAGR) 0.19 0.11 0.29

Growth

14 metrics
MetricKROCEOLN
Revenue growth (1Y) 2.7% -2.2% 0.6%
Revenue CAGR (3Y) 5.1% -1.9% -5.1%
Gross profit growth (1Y) -35.8% -5.7% -20.5%
Gross profit CAGR (3Y) 5.4% -3.3% -33.6%
Operating income growth (1Y) -128.3% 11.1% -174.4%
Operating income CAGR (3Y) -32.2% -39.7% -27.9%
Net income growth (1Y) -262.1% 29.1% -1,072%
Net income CAGR (3Y) -69.9% -42.8% -30.9%
EPS growth (1Y) -261.9% 29.0% -1,309%
EPS CAGR (3Y) -43.1% -42.8% -31.6%
Operating cash flow growth (1Y) 2,202% -3.5% -32.9%
Operating cash flow CAGR (3Y) 58.1% -16.2% -38.3%
Free cash flow growth (1Y) 236.6% 12.0% -62.9%
Free cash flow CAGR (3Y) 37.5% -13.2% -54.2%

Profitability

14 metrics
MetricKROCEOLN
Gross margin 11.8% 20.9% 6.9%
EBITDA margin 1.6% 1.7% 5.9%
Operating margin -1.7% -7.1% -1.6%
Pretax margin -5.0% -11.6% -4.0%
Net margin -5.6% -12.0% -2.9%
FCF margin 3.4% 7.3% 1.5%
Operating cash flow margin 4.4% 10.1% 4.6%
Return on equity -14.6% -25.4% -11.4%
Return on assets -6.2% -5.3% -2.6%
Return on invested capital -2.4% -4.1% -1.6%
Return on capital employed -2.2% -3.9% -1.8%
Asset turnover 1.1x 0.5x 0.9x
Cash conversion (OCF / net income) -0.8x -0.8x -1.6x
Stock comp / revenue – 0.3% 0.3%

Financial Health

11 metrics
MetricKROCEOLN
Debt / assets 32.7% 56.1% 40.7%
Debt / equity 0.8x 2.6x 1.8x
Net debt / EBITDA 17.7x 63.7x 7.3x
Debt / FCF 8.6x 17.0x 30.1x
Liabilities / assets 56.9% 78.6% 77.0%
Equity / assets 43.1% 21.4% 23.0%
Interest coverage -0.6x -1.0x -0.6x
Current ratio 3.3x 1.4x 1.4x
Quick ratio 1.5x 0.8x 0.8x
Cash ratio 0.1x 0.3x 0.1x
Altman Z-score 1.76 1.29 1.52

Shareholder Returns

7 metrics
MetricKROCEOLN
Dividend yield 2.6% 0.2% 5.0%
Net buyback yield – – 0.9%
Shareholder yield 2.6% 0.2% 5.9%
Payout ratio (earnings) -21.0% -1.1% –
Payout ratio (FCF) 34.6% 1.8% –
Dividend growth (1Y) 0.0% -91.8% –
Dividend CAGR (3Y) -36.0% -65.0% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusKROCEOLN
Forward P/E 20.0xFY2026 7.6xFY2026 –
EPS, next fiscal year $0.38FY2026 $6.33FY2026 $-0.61FY2026
EPS growth, next FY – +59.0%FY2026 –
EPS growth, the year after +63.2% -0.2% –
Revenue, next fiscal year $2.13BFY2026 $9.75BFY2026 $6.47BFY2026
Revenue growth, next FY +14.3%FY2026 +2.2%FY2026 -4.6%FY2026
Revenue growth, the year after -4.3% +7.8% +16.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersKROCEOLN
Held by institutions 16.0% 100.0% 99.7%
Institutions holding 130 458 410
Change in shares held, QoQ +4.6% +10.8% +1.5%
Institutions buying 74 246 214
Institutions selling 34 138 120
Buyers to sellers 2.18 1.78 1.78

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

KROCEOLN
KRO 1.00 0.38 0.44
CE 0.38 1.00 0.64
OLN 0.44 0.64 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, KRO, CE and OLN?

Celanese (CE) is the largest by market capitalisation: Kronos Worldwide (KRO) $888.57M, Celanese (CE) $5.36B, Olin (OLN) $1.83B.

Which company is growing faster?

Kronos Worldwide (KRO) grew revenue fastest over the trailing twelve months: Kronos Worldwide (KRO) +2.7%, Celanese (CE) -2.2%, Olin (OLN) +0.6%.

Which company is more profitable?

Olin (OLN) has the highest net margin (Kronos Worldwide (KRO) -5.6%, Celanese (CE) -12.0%, Olin (OLN) -2.9%). On return on invested capital, Olin (OLN) leads (Kronos Worldwide (KRO) -2.4%, Celanese (CE) -4.1%, Olin (OLN) -1.6%).

Which stock has performed better?

Over the past year Kronos Worldwide (KRO) returned the most: Kronos Worldwide (KRO) +53.5%, Celanese (CE) +14.0%, Olin (OLN) -33.7%. Over five years, Kronos Worldwide (KRO) compounded fastest (Kronos Worldwide (KRO) -10.1%/yr, Celanese (CE) -21.7%/yr, Olin (OLN) -22.0%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Kronos Worldwide (KRO) has the highest dividend yield: Kronos Worldwide (KRO) 0.03%, Celanese (CE) 0.00%, Olin (OLN) 0.00%. Olin (OLN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Celanese (CE) has been the steadiest (Kronos Worldwide (KRO) 59.2%, Celanese (CE) 51.7%, Olin (OLN) 53.3%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, KRO, CE and OLN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Kronos Worldwide (KRO) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.